Modernization of North Carolina s HIV control measures

Similar documents
Disclosure. Speakers are required to disclose any commercial relationships before today s presentation. MidAtlantic AIDS Education and Training Center

Biomedical Prevention in HIV

Using anti-hiv drugs for prevention

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

Post-Sexual Exposure Prophylaxis (npep)

HIV Treatment as Prevention (TasP)

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP

Care Coach Collaborative Model Bridging Gap of Medical Linkage for HIV Positive Inmates Go home, kiss your Mother, and come into our offices. (Patsy F

GOAL1 GOAL 2 GOAL 3 GOAL 4

PrEP for HIV Prevention. Adult Clinical Guideline from the New York State Department of Health AIDS Institute

OR: Steps you can take in the clinic to prevent HIV infections

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium

Strategic use of antiretroviral drugs to prevent HIV transmission

HIV - Preventing New Infections: New Options, Readjusted Approaches

QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE

Anti Retroviral Traitment (ARVs)

PrEP and npep for HIV Prevention. Harry Rosado-Santos MD, FACP Associate Professor UU School of Medicine

Ending The HIV/AIDS Epidemic in America

A Sex-informed Framework for HIV Prevention. Robert M. Grant, M.D., M.P.H. Betty Jean and Hiro Ogawa Endowed Investigator

PrEP and Behavioral Strategies for HIV Prevention. Douglas Krakower, MD January 30, 2014

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa

Fertility Desires/Management of Serodiscordant HIV + Couples

High Impact Prevention: Science, Practice, and the Future of HIV

Biomedical HIV Prevention & TaP Treatment as Prevention 2013

Receptive Anal Intercourse and HIV Infection

As a result of this training, participants will be able to:

Comprehensive HIV/AIDS Resources and Linkages for Inmates (CHARLI) and Care Coordination (CC) Collaborative. Care Coordination

Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence

Multiple choice questions: ANSWERS

Five Things to Know About Antiretroviral Therapy (ART) & HIV Prevention

An International Antiviral Society-USA

Letter of Amendment # 3 to:

Sexual Health reproduction in reference to treatment as/for prevention

The Latest on HIV Testing. Dominika Seidman, MD MAS

I M ENDING HIV PATIENT INFORMATION. endinghiv.org.au/prep

HIV Treatment as Prevention (TasP) Guideline and protocol

Module 1: HIV epidemiology, transmission and prevention

HIV Update Objectives. Epidemiology. Epidemiology, Transmission and Natural History. Transmission Risk by Exposure. Transmission 9/29/2014

FY 2018 PERFORMANCE PLAN. Public Health/ CHSB

PrEP Home Checklist v1.0

Case Studies in PrEP Management. Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016

HIV Prevention in Clinical Care Settings

Treat All : From Policy to Action - What will it take?

Culturally Relevant Linkages to Care

Towards universal access

Non-Occupational Post-Exposure HIV Prophylaxis npep

Clinical Education Initiative PRE-EXPOSURE PROPHYLAXIS. Speaker: Antonia Urbina, MD

Unmet Oral Health Needs of Persons Living With HIV/AIDS in the United States

Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013

Pre-Exposure Topical Microbicides and Oral Prophylaxis Trials:

In 2015, blacks comprised 12% of the US population, but accounted for 45% of those infected with HIV. Whites were 62% of the population, but

Cleveland Prevention Update. Zach Reau HIV Prevention Program Manager Ohio Department of Health

HIV prophylaxis for health care providers. Dr. A. K. M. Humayon Kabir Assistant Professor Department of Medicine Dhaka Medical College Hospital

Implementing HIV Screening at Hub and Spoke Sites and Other Drug Treatment Settings

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84

PEP, PREP, HPTN052 and MLN2238

HIV Partner Services in HIV Care Programs

Community Health Workers (CHWs) in HIV Services: Insights from Virginia. November 16, 2017

Program to control HIV/AIDS

Addendum to Public Health Approach to HIV Case Management by the Council of Ontario Medical Officers of Health HIV Working Group. Full report follows.

HIV Clinical Update- HIV prevention

Arizona State Office of Rural Health Webinar Series

WVU Occupational Medicine Program for evaluation and treatment of persons exposed to Lentivirus Vectors

Heterosexual men: the HIV minority

PEP and PREP. Dr David Hawkins Chelsea and Westminster Hospital

Getting to Zero in California: Integration of HIV Prevention and Surveillance

Bruce D. Agins, MD MPH Medical Director, AIDS Institute Adherence 2017; Miami

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland. An update for registered practitioners September 2017

GLOBAL AIDS MONITORING REPORT

Section 10 Counseling Considerations

Study finds PEP not 100% effective in preventing HIV infection

HIV Testing and HIV Prevention

PERFORMANCE INDICATOR REFERENCE SHEETS FOR KEY POPULATIONS

Elton Naswood, Michelle Enfield & Mattee Jim

PrEP in the Real World: Clinical Case Studies

South African Guidelines for the Safe Use of. Dr. Oscar Radebe

L2C IN NYC RYAN WHITE PART A PLANNING COUNCIL INTEGRATION OF CARE COMMITTEE DECEMBER 3 RD, DECEMBER 17 TH 2014

Women and PrEP: What are local health departments doing?

HIV and the Buckeye State

Understanding the Results of VOICE

Implementation of PrEP in Kenya

FAMILY HIV CENTER NJ CARES SANE

HIV In The Navy and Marine Corps A Discussion For Health Care Professionals 2 December 2013

Evidence-based Strategies to Address Retention in HIV Care

One of your office personnel

2016 NYS HIV Quality of Care Review

Looking to the Future in HIV Prevention:

DEPARTMENT OF GENITO-URINARY MEDICINE HEPATITIS B

Evolving HIV Treatment Paradigms What we need to know

HIV Prevention Service Provider Survey 2014

Using PrEP as Harm Reduction. Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000.

Fast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs

As a result of this training, participants will be able to:

Why are the targets a game-changer? What is the Fast-Track Cities Initiative and its connection to ?

Available In person Courses

CROI 2015: HIV Prevention Updates

The AIDS Education & Training Center Program (AETC): Supporting HIV Education through the AIDS Education and Training Centers

Clinical Education Initiative OCCUPATIONAL POST- EXPOSURE PROPHYLAXIS. Antonio E. Urbina, MD

Objectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care.

Transcription:

Modernization of North Carolina s HIV control measures North Carolina Division of Public Health Victoria Mobley, MD MPH Evelyn Foust, MPH CPM Agenda Introduction Summary of scientific evidence used to inform the changes Major changes to the NC HIV control measures Update on NC HIV continuum and goals for ending the epidemic Common issues LHDs deal with re: HIV control measures 1

Why change North Carolina s HIV control measures? The first HIV control measures were implemented in 1988 First AIDS case diagnosed in 1981 First NC AIDS case diagnosed in 1984 There have been significant advances in HIV treatment and prevention efforts over the last 30 years 8 one pill/day regimens Pre exposure Prophylaxis Post exposure Prophylaxis Advances in long acting medication research HIV vaccine trials EVIDENCE: Undetectable=Untransmittable HPTN 052 Study http://www.nejm.org/doi/full/10.1056/nejmoa1600693#t=article PARTNER Study https://jamanetwork.com/journals/jama/fullarticle/2533066 Opposites Attract Study http://i base.info/htb/32190 2

HPTN 052 study: Does antiretroviral therapy (ART) prevent the sexual transmission of HIV 1 infection Phase III randomized, controlled trial Enrolled participants at 13 sites in 9 countries Partners followed for 8509 person years HPTN 052 study: Does antiretroviral therapy (ART) prevent the sexual transmission of HIV 1 infection 1,763 sero discordant couples Phase III randomized, controlled trial Enrolled participants at 13 sites in 9 countries Partners followed for 8509 person years 886 HIV+ patients ART started immediately (CD4 >350) 877 HIV+ patient ART delayed start (CD4 250) 3

HPTN 052 study: Does antiretroviral therapy (ART) prevent the sexual transmission of HIV 1 infection 1,763 HIV serodiscordant couples Phase III randomized, controlled trial Enrolled participants at 13 sites in 9 countries Partners followed for 8509 person years 886 HIV+ patients ART started immediately (CD4 >350) 877 HIV+ patient ART delayed start (CD4 250) *93% Reduction in HIV 1 transmission* HPTN 052: Delving into the details 93% reduc on in transmission risk No risk 8 linked transmissions in early ART arm 4 diagnosed very soon after ART started *So unlikely to have been virally suppressed 4 diagnosed in couples where HIV+ partner was not virally suppressed 4

HPTN 052: Conclusion There were NO linked HIV transmissions among couples where the HIV positive partner was stably virally suppressed. Game changer HIV 1 treatment was now proven to prevent HIV transmission. Worldwide mandate to get all persons living with HIV into care and on ART. HPTN O52: Major Limitation The majority of the couples were heterosexual (97%), so unclear whether the reduction in transmission risk would be similar for malemale partnerships? 5

Estimated Per Act Probability of Acquiring HIV from an Infected Source, by Exposure Act* Type of Exposure Risk per 10,000 Exposures Parenteral Blood Transfusion 9,250 Needle Sharing During Injection Drug Use 63 Percutaneous (Needle Stick) 23 Sexual Receptive Anal Intercourse 138 Insertive Anal Intercourse 11 Receptive Penile Vaginal Intercourse 8 Insertive Penile Vaginal Intercourse 4 Receptive Oral Intercourse Low Insertive Oral Intercourse Low Other^ Biting, Spitting, Throwing body fluids, Sharing sex toys Negligible PARTNER STUDY Prospective cohort study Enrollment at 75 sites in 14 countries Both heterosexual and male male couples Reported routine sex without condoms Opposites Attract Study Prospective cohort study Enrollment at multiple sites in 3 countries All male male couples Report having anal sex at least 1x/month HIV positive partner on ART HIV negative partner not on PrEP HIV positive partner on ART No PrEP restrictions Observations 44,450 sexual acts of any type without condoms ~21,030 were anal sex acts STIs diagnosed in 17.5% of study participants ~ 17,000 anal sex acts without condoms 70% while HIV negative partner was not on PrEP STIs diagnosed in 6% of study participants 6

Summary of scientific evidence Three large international studies Thousands of HIV sero discordant couples observed Followed for thousands of person years More than 70,000 sex acts without condoms: NO linked HIV transmission events among serodiscordant couples where the HIV positive partner was taking ART and stably virally suppressed. Major changes to the North Carolina HIV control measures The BIGGEST change underlining the modernization of the HIV control measures is the recognition of when there is a risk for sexual transmission 7

Defining PLWH who are not at risk for sexually transmitting the virus To fall into this group, the PLWH must meet ALL of the below criteria. In HIV care, meaning they are being routinely seen by a clinician who manages their HIV disease Adherent to their HIV clinician s treatment plan, which includes: Taking HIV antiretroviral therapy as their clinician directs Attend all scheduled medical appointments or rescheduling in advance when issues arise and an appointment cannot be kept Adhering to all clinician ordered HIV laboratory testing aimed at routine monitoring of HIV RNA level Virally suppressed for at least 6 months (HIV RNA levels below 200 copies per milliliter) at the time of sexual intercourse **The burden to prove the PLWH meets all the criteria to be non infectious is on the client, not public health.** Changes to public health requirements changes to public health messaging Since public health law is intended to prevent the transmission of disease, PLWH who are not at risk for sexually transmitting HIV are no longer legally required to use condoms or notify future sexual partners BUT Public Health still advises and encourages all sexually active individuals including PLWH to: Have an open and honest discussions with all sexual partners regarding their sexual history and risk Use condoms to prevent the transmission of other STIs 8

Other Changes to the HIV control measures For PLWH who remain infectious: 1) They must notify all future sexual partners of their status AND 2) Use a condom with all sexual encounters unless: the sexual intercourse partner is also HIV positive the sexual intercourse partner is taking PrEP as directed by a provider the sexual intercourse occurred in the context of a sexual assault in which the PLWH was the victim Other Changes to the HIV control measures Organ Donation Permissible when done as part of a clinical research study meeting the regulations described in the federal HOPE ACT (HIV positive organ donation to HIV positive recipients) Notification of exposed partners (two options) Client can do themselves, OR Can give names to DIS who will perform confidential notification Determination of significant transmission risk Incorporated the official CDC s risk estimates by reference into update. Isolation Orders Addition of important referral resources to strengthen effectiveness of the isolation orders 9

North Carolina s HIV Epidemic North Carolina HIV Infection Rates by Year of Diagnosis, 2000 2016 10

HIV Continuum of Care in the US, 2014 1,000,000 NHAS goal by 2020: 90% Total Number of PLWH 800,000 600,000 400,000 200,000 85% 62% 66% 48% 48% NHAS goal by 2020: 80% 49% 0 Total Diagnosed & Reported Receipt of care Retained in care Virally Suppressed Total Number of PLWH 38,000 33,000 28,000 23,000 18,000 13,000 8,000 3,000 HIV Continuum of Care in North Carolina, 2016 NHAS goal by 2020: 90% 90% 71% 66% 62% NHAS goal by 2020: 80% 62% 2,000 Total Diagnosed & Reported 1 care visit Retained in care Virally Suppressed 11

HIV Continuum of Care in North Carolina, 2016 38,000 Total Number of PLWH 33,000 28,000 23,000 18,000 13,000 NHAS goal by 2020: 90% 90% 71% 66% NHAS goal by 2020: 80% 62% 83% 76% 8,000 3,000 2,000 Total Diagnosed & Reported 1 care visit NC RW part B HMAP Retained in care Virally Suppressed Common Scenarios presented to LHDs 1) HIV positive individual diagnosed with a new STI. 2) HIV positive individual reported for not disclosing status and/or not using a condom. 3) HIV positive individual accused of transmitting HIV to another person(s). 4) HIV positive individual accused of lying about HIV status to sex partner. 12

Using the updated control measures to efficiently utilize public health resources? Potential control measure violation Assess HIV care and viral load status In care, adherent to treatment plan and durably virally suppressed Standard risk reduction counseling Not in care, not adherent to treatment plan or not durably virally suppressed This is where public health resources are needed! Utilizing the updated HIV control measures In addition to risk reduction counseling Assess barriers to linkage and retention in HIV care Link to HIV care and treatment or a SBC/case manager ±Isolation order that addresses barriers to HIV care 13

How can the modernized HIV control measures assist LHDs in everyday responsibilities Incentivize PLWH to get in and remain engaged in care Allows Public Health to focus time and resources on PLWH who need our assistance getting into care Provides LHDs with tools to maximize success of intervention efforts Provides clear guidance on how to handle common community issues (i.e. bites in schools) Final Thoughts Reported HIV data allows us to see health status and focus interventions at the individual and community level. Efforts focused on getting people into care and treatment, and keeping them there, encourage trust, and are a better fit with our public health mission. Collaboration is earned. Partnership required. HIV Prevention and awareness needs to be reenergized at local and state level including HIV PrEP. Find and share best practices. 14

Questions? 15